Assessing the clinical value of targeted massively parallel sequencing in a longitudinal, prospective population-based study of cancer patients

INTRODUCTION: Recent discoveries in cancer research have revealed a plethora of clinically actionable mutations that provide therapeutic, prognostic and predictive benefit to patients. The feasibility of screening mutations as part of the routine clinical care of patients remains relatively unexplor...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, S Q, Fellowes, A, Doig, K, Ellul, J, Bosma, T J, Irwin, D, Vedururu, R, Tan, A Y-C, Weiss, J, Chan, K S, Lucas, M, Thomas, D M, Dobrovic, A, Parisot, J P, Fox, S B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Genetics and Genomics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402458/
https://www.ncbi.nlm.nih.gov/pubmed/25742471
http://dx.doi.org/10.1038/bjc.2015.80

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402458/
https://www.ncbi.nlm.nih.gov/pubmed/25742471
http://dx.doi.org/10.1038/bjc.2015.80

Ejemplares similares